Can asthma be predicted at birth?

Early life appears optimal for prevention of asthma, but interventions require a target population, and to date asthma cannot be clearly identified at birth.

The study included 614 healthy term babies with lung function measured at birth. There was a 10-year follow-up visit including skin prick test (SPT) for allergens.

The analysis included 37 variables, among them:

- lung function
- cord blood total immunoglobulin E
- soluble CD14

Parental allergic disease was insufficient to identify high-risk populations.

The model predicted a history of asthma correctly in 75% of children. However, it was not good enough - an intervention applied to predicted high-risk children would be started more often in children without asthma.

CD14 is a component of the innate immune system that exists in 2 forms:

- anchored into the membrane by a glycosylphosphatidylinositol (GPI anchor) tail (mCD14)
- soluble form (sCD14)

Innate immune system recognizes LPS via the LPS signal transduction pathway, which has the trimolecular complex of CD14/TLR4/MD2 at the core. CD14 was the first described pattern recognition receptor (PAMP receptor).


In the initial stages of an immune response, the innate immune system recognizes the presence of pathogens and provides the first line of defense. This video is from: Janeway's Immunobiology, 7th Edition Murphy, Travers, & Walport. Source: Garland Science.

References:

Can childhood asthma be predicted at birth? Lødrup Carlsen KC, Mowinckel P, Granum B, Carlsen KH. Clin Exp Allergy. 2010 Oct 6. doi: 10.1111/j.1365-2222.2010.03620.x.
Both low and high levels of cord blood 25(OH) vitamin D were associated with increased aeroallergen sensitization. JACI, 2011.

Mast cell activation syndrome (MCAS): what is it?

Role of mast cells in allergy had remained undetermined until the discovery of IgE in 1966. Then, IgE purified from many Liters of plasma, which had been donated from a patient with fatal myeloma, was distributed to researchers all over the world (http://buff.ly/12sD3cO).

The term mast cell activation syndrome (MCAS) is finding increasing use as a diagnosis for subjects who present with signs and symptoms involving:

- skin
- gastrointestinal tract
- cardiovascular system
- neurologic complaints

Such patients often have undergone multiple extensive medical evaluations by different physicians in varied disciplines without a definitive medical diagnosis until the diagnosis of MCAS is applied.

Mast cells are traditionally viewed only as IgE-activated histamine-providing effector cells of allergic inflammation.


Mast cells. Image source: Wikipedia, public domain.

MCAS as a distinct clinical entity has not been generally accepted, and there are no definitive criteria for diagnosis.

The authors discuss proposed criteria in the context of other disorders involving mast cells.


Blood cell lineage. Image source: Wikipedia.


Mast cells (mind map).

References:
Mast cell activation syndrome: Proposed diagnostic criteria. Akin C, Valent P, Metcalfe DD. J Allergy Clin Immunol. 2010 Oct 27.
Mast cell activation syndromes: definition and classification http://buff.ly/XlrDje
Mast Cell Activation Disorders - 2014 free full text review http://buff.ly/1kPDdzo

Mast Cell Disorders - figures:

No Significant Ocular Side Effects After 2 Years of Nasal Steroids Use By Children With Allergic Rhinitis



Treatment Options for Allergic Rhinitis (click to enlarge the image).

The study group included 150 children (8-15 years of age) who had used intermittent intranasal budesonide for more than 2 years for allergic rhinitis.

The average age was 11.7 years and the mean steroid dosage used was 93 μg daily with 42 g total steroid use during treatment.

There was no statistically significant difference between the study and control groups according to ocular findings. Relevant eye pathology including cataract formation, corneal ectasia, ocular hypertension or glaucoma, and dry eye were not observed in any of the patients in the study group.

A 2-year treatment of children with allergic rhinitis prescribed intermittent intranasal budesonide at an average daily dose of approximately 100 μg is not associated with ocular side effects such as cataract, glaucoma, corneal ectasia, and abnormal tear function.

References:

Lack of Ocular Side Effects After 2 Years of Topical Steroids for Allergic Rhinitis. Ozkaya E, Ozsutcu M, Mete F. J Pediatr Ophthalmol Strabismus. 2010 Oct 21:1-7. doi: 10.3928/01913913-20101018-03.
Growth Velocity Reduced by 0.27 cm with Fluticasone Nasal Spray daily for 1 years in Prepubescent Children http://buff.ly/1jNf4Ny
The very low (≤1%) systemic bioavailability of newer INSs minimizes the systemic adverse effects http://goo.gl/5gcO6
Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitis. http://goo.gl/xb2k7
Risk of development of cataracts and/or glaucoma from inhaled corticosteroids http://goo.gl/prWJB

Toll-like receptor 4 agonist monophosphoryl lipid A augments SLIT

Sublingual immunotherapy (SLIT) allergy vaccines have a good safety profile, but opinions vary on their efficacy, and treatment regimens are often lengthy.

This German study assessed the effects of the Toll-like receptor 4 agonist monophosphoryl lipid A (MPL®) when combined with grass pollen SLIT. This is the first reported study of adjuvanted SLIT.


The curved leucine-rich repeat region of toll-like receptors, represented here by TLR3. Image source: Wikipedia.

Patients in the groups given SLIT containing the highest amount of MPL experienced the highest proportion of negative nasal challenge tests after 10 weeks (44-47%, vs. 20% with placebo).

These results suggest that SLIT preparations containing MPL alter the immunological response to grass antigens after 3 weeks of exposure.


Pathogen Recognition Receptors, TLRs. This video is from: Janeway's Immunobiology, 7th Edition Murphy, Travers, & Walport. Source: Garland Science.

References:
Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study. Pfaar O, Barth C, Jaschke C, Hörmann K, Klimek L. Int Arch Allergy Immunol. 2010 Oct 25;154(4):336-344.

Staphylococcal enterotoxins may play a role in severe asthma

Determinants of severe refractory asthma (SRA) are not well characterized. Staphylococcus aureus enterotoxins with superantigenic activity have been associated with upper and lower airway inflammation.

The study included 109 patients with SRA and 101 patients with non-severe asthma, followed for 12 months.

A significant risk for severe asthma was associated with:

- female gender [Odds Ratio (OR)=2.04]
- history of wheezing in childhood (OR=2.47)
- presence of hypersensitivity to aspirin (OR=1.96)
- body mass index (OR=3.08)

The mean level of enterotoxin-specific IgE was 3-fold higher in patients with severe asthma when compared to patients with nonsevere asthma.

Serum-specific IgE to enterotoxins was significantly associated with low respiratory function parameters (FEV(1), FEV(1) /FVC and MEF 25/75) and increased airway reversibility in response to albuterol.

The presence of specific IgE to enterotoxin carried a risk for patients to have serum total IgE level above 100 kU/l (OR=7.84).

I wonder if treating the suspected staphylococcal skin colonization would make a difference in patients with severe asthma. For example, treatment with cephalexin followed by weekly bleach baths was beneficial in patients with atopic dermatitis. At baseline, S. aureus was cultured from 87% of skin and 81% of nares of patients (7% of skin bacteria and 4% of nares bacteria were methicillin resistant [MRSA]). S. aureus (enterotoxins), M sympodialis, and allergens are trigger factors of atopic dermatitis - they stimulate dendritic cells (JACI, 2012).

References:

Kowalski ML, Cieślak M, Pérez-Novo CA, Makowska JS, Bachert C. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 2010; DOI: 10.1111/j.1398-9995.2010.02379.x.
Bleach Baths Improve Atopic Dermatitis - How To Use Them?
Colonization of S. aureus in early childhood eczema (72.7%) originates from childrens' own noses, not from mothers http://goo.gl/0fptY
New test (KeyPath) determines whether Staph. aureus infections are methicillin resistant (MRSA) within 5 hours http://goo.gl/w1wWt
Staphylococcus aureus biofilm and and superantigens are associated with chronic sinusitis, cause T-helper 2 skewing http://bit.ly/ngnxBe

Diagnostic Criteria for Common Variable Immunodeficiency (CVID): Probable and Possible Diagnosis

The diagnostic criteria are divided into three categories: definitive, probable, and possible. There are no criteria for definitive diagnosis of Common Variable Immunodeficiency (CVID) at this time.

To guard against the inclusion of patients who have polymorphic variants in the genes associated with immunodeficiency and to specify the clinical or laboratory finding that is most consistently abnormal in a particular disorder, the patient must fulfill an inclusion criterion that is characteristic of the disorder.

Definitive diagnosis

Patients with a definitive diagnosis are assumed to have a greater than 98% probability that in 20 years they will still be given the same diagnosis. Mutation detection is the most reliable method of making a diagnosis but a single mutation is rarely found in CVID.

Probable diagnosis

Patients with a probable diagnosis are those with all of the clinical and laboratory characteristics of a particular disorder but who do not have a documented abnormality in the gene, the mRNA, or the protein that is known to be abnormal in the disorder. They are assumed to have a greater than 85% probability that in 20 years they will be given the same diagnosis.

Probable diagnosis of CVID:

Male or female patient who has a marked decrease (at least 2 SD below the mean for age) in serum IgG AND IgA and fulfills all of the following criteria:

1. Onset of immunodeficiency at greater than 2 years of age.

2. Absent isohemagglutinins and/or poor response to vaccines.

3. Defined causes of hypogammaglobulinemia have been excluded

Possible diagnosis

Patients with a possible diagnosis are those that have some but not all of the characteristic clinical or laboratory findings of a particular disorder.

Possible diagnosis if CVID:

Male or female patient who has a marked decrease (at least 2 SD below the mean for age) in one of the major isotypes (IgM, IgG, and IgA) and fulfills all of the following criteria:

1. Onset of immunodeficiency at greater than 2 years of age.

2. Absent isohemagglutinins and/or poor response to vaccines.

3. Defined causes of hypogammaglobulinemia have been excluded

Clinical features of CVID

Most patients with CVID are diagnosed with immunodeficiency in the second, third, or fourth decade of life, after they have had several pneumonias; however, children and older adults may be affected.

Viral, fungal, and parasitic infections as well as bacterial infections may be found.

The serum concentration of IgM is normal in about half of the patients.

Abnormalities in T cell numbers or function are common. The majority of patients have normal numbers of B cells; however, some have low or absent B cells.

Approximately 50% of patients have autoimmune manifestations. There is an increased risk of malignancy.

Differential diagnosis of hypogammaglobulinemia includes drug-induced, for example secondary to glucocorticoids (steroids).



Typical pattern of immunoglobulin levels (IgG, IgA, IgM) in humoral immunodeficiency. Click here to enlarge the table.

References

Diagnostic Criteria for Primary Immunodeficiencies. Mary Ellen Conley, Luigi D. Notarangelo, and Amos Etzioni Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical Immunology, Vol. 93, No. 3, December, pp. 190–197, 1999.

Recognizing Primary Immune Deficiency in Clinical Practice. Clinical and Vaccine Immunology, March 2006, p. 329-332, Vol. 13, No. 3.

What are the normal serum immunoglobulin levels (IgG, IgA, IgM)?

Serum levels of IgM, IgG and IgA vary with age, gender and race.

The IgG and IgA concentrations in children show a gradual rise with increasing age. The IgA level is generally about the same in both sexes. Girls typically have higher IgM and IgG levels than boys.

The confidence interval bounded by two standard deviations about the mean excludes 5% of apparently healthy controls.

Elevated IgM, low IgA, low IgG, low IgM, and elevated IgA are the commonest changes observed in apparently healthy humans.

Humoral immunodeficiency is commonly defined as IgG, IgM or IgA level that is two standard deviations (2 SD) below the mean level for IgG, IgM or IgA, respectively, for the particular age group and gender.


Serum levels of IgM, IgG and IgA. Source: Pediatrics, 1966 and Immunologic disorders in infants and children, by E. Richard Stiehm, Hans D. Ochs, Jerry A. Winkelstein.



Typical pattern of immunoglobulin levels (IgG, IgA, IgM) in humoral immunodeficiency. Click here to enlarge the table.

References:

Serum immunoglobulin levels in healthy children and adults. J. W. Stoop, B. J. M. Zegers, P. C. Sander, and R. E. Ballieux. Clin Exp Immunol. 1969 January; 4(1): 101–112.

The relationship of race, sex, and age to concentrations of serum immunoglobulins expressed in international units in healthy adults in the USA. S. E. Maddison, C. C. Stewart, C. E. Farshy, and C. B. Reimer. Bull World Health Organ. 1975; 52(2): 179–185.

Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM. D Isaacs, D G Altman, C E Tidmarsh, H B Valman, and A D Webster. J Clin Pathol. 1983 October; 36(10): 1193–1196.


Serum Immunoglobulin Levels Throughout the Life-Span of Healthy Man. Ann of Int Med, November 1, 1971, Vol. 75 no. 5 673-682.

"Toxic schools": Could mold in school make your child sick?

Despite growing legal claims across the country involving indoor air quality, there is no generally accepted standard for how much mold can be in a room before it becomes unsafe.

Sensitivity levels can vary widely from person to person. If mold is growing on the ceiling or inside the wall of a classroom, some children will not be affected at all. Others, however, might experience flu-like symptoms such as runny noses, coughing and breathing difficulties.

Some types of mold emit toxins that can elicit more severe responses.

For example, Aspergillus and Stachybotrys ("black mold") have been linked to lung and respiratory infections, and have forced the closure of homes and schools across the country.

Various fungi including Penicillium and Aspergillus spp. growing in axenic culture. Image source: Wikipedia, Dr. David Midgley Cultures: Dr. David Midgley University of Sydney, Australia, Creative Commons Attribution ShareAlike 2.5 License.

Regarding the mold/asthma link, certain findings have been found consistently: 1. the mold has to be visible, 2. the mold has to be in the room where they live, 3. the patient does not have to be allergic to mold to have symptoms because the some molds release irritant volatile compounds in the air.

What are the most common fungal allergens?

Respiratory exposure to a wide range of fungal spores and fragments is almost constant and 189 fungal species are thought to produce allergens.

Many fungi are capable of causing IgE-mediated hypersensitivity in humans. However, the most predominant fungi implicated in allergy belong to the genera Aspergillus, Alternaria, Cladosporium, and Penicillium.

References

Are schools making kids sick? 30% have mold, indoor air pollutants that provoke respiratory diseases like asthma - CNN, 2012.
What are the most common fungal allergens?
Poor air quality in classrooms related to asthma and rhinitis. Thorax, 2012.
Exposure to visible mold and/or dampness during first 2 years of life associated with asthma risk - but odds ration (OR) was very close to 1.0. Allergy, 2011.

Aqueous cream 'aggravates eczema' - this does not include Eucerin and Aquaphor

Scientists have found that aqueous cream used to treat eczema thinned the skin after a few weeks of use. This is because it contains a detergent rather than just moisturisers.

"Aqueous Cream BP" is widely prescribed to British patients with eczema to relieve skin dryness. The formulation contains sodium lauryl sulphate (SLS), a chemical that is a known skin irritant and a commonly used excipient in personal care and household products.

The University of Bath study, published in the British Journal of Dermatology looked directly at its effects on the skin when used regularly. Volunteers, none of whom had eczema, rubbed it into their forearms every day over a four-week period. They found the thickness of the stratum corneum (SC), the outermost skin layer, was reduced by about 10% in this time.

The application of "Aqueous Cream BP", containing ∼1% SLS, reduced the SC thickness of healthy skin and increased its permeability to water loss. These observations call into question the continued use of this emollient on the already compromised barrier of eczematous skin.

Sodium lauryl sulphate detergent in the cream was affecting a thin layer of fats lying on top of the skin.

According to BBC, "To use this cream on eczematous skin, which is already thin and vulnerable to irritation, is likely to make the condition even worse. "Aqueous cream contains sodium lauryl sulphate, which is a fairly heavy duty detergent. Sadly it is widely used - one it's cheap and two, it's prescribing habit. This layer of skin will grow back over time, but if you're using aqueous cream on it every day, it simply won't get the chance."

The UK National Eczema Society recommends alternatives such as white soft paraffin or even other types of emollient without such a high sodium laurel sulphate content.

The moisturizer creams that I typically recommend for use in atopic dermatitis (Eucerin and Aquaphor) do not contain sodium lauryl sulphate. The ingredients can be verified on the manufacturer's website.



Atopic Dermatitis Treatment - Illustrated (click here for full size image).

Barrier creams and emollients for AD include CeraVe (http://cerave.com), Mimyx, EpiCeram (http://epiceram-us.com), Eletone, Theraplex (http:/theraplex.com), Eucerin and Aquaphor.

References

Effect of Aqueous Cream BP on human stratum corneum in vivo. M. Tsang, R.H. Guy. British Journal of Dermatology, Volume 163, Issue 5, pages 954–958, November 2010.

Aqueous cream 'aggravates eczema'. BBC.
50% of school children with eczema (atopic dermatitis) may actually have allergic contact dermatitis (study) http://goo.gl/Bq3ZB

Prescription barrier creams include Atopiclair, EpiCeram, or Hylatopic Plus.

Image source: Skin layers. Wikipedia, public domain.

Amazon affiliate links:

Urticaria Severity Score (USS) for quantifying urticaria severity

Despite the existence of numerous quality-of-life questionnaires, there is a need for a simple and validated tool for evaluation and monitoring patients with chronic urticaria.

The Urticaria Severity Score (USS) is a new chronic urticaria-specific questionnaire that has 12 questions and 7 response options per question.

The USS was pilot-tested in 28 patients with symptomatic chronic urticaria. A modified version was tested in 80 patients and compared with the validated Dermatology Life Quality Index (DLQI).

There was a positive correlation between the USS and DLQI at baseline (r = 0.64) and follow-up (r = 0.69).

The USS was more sensitive in detecting symptom improvement than the DLQI.

The study authors concluded that the USS is a valid and reliable instrument for monitoring urticaria severity. The USS is more sensitive than the DLQI for quantifying urticaria severity.

References:
The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. Jariwala SP, Moday H, de Asis ML, Fodeman J, Hudes G, de Vos G, Rosenstreich D. Ann Allergy Asthma Immunol. 2009 Jun;102(6):475-82.
Image source: Urticaria, Wikipedia, public domain.

New Medicare Rules for Billing Flu Vaccines in 2011

Medicare (CMS) has announced new billing codes for influenza vaccines effective January 1, 2011.

The administration of the vaccines continues to be coded G0008; and the diagnosis code remains V04.81.

For children under age 3 years, the vaccine codes remain 90655 – 90657. For those over age 3, the codes are now product based and range from Q2035 – Q2039.

The code for nasal influenza vaccine remains 90660 and the administration to immune compromised patients remains 90662.

50,000 influenza deaths occur annually in the United States; many of these deaths are preventable with the vaccine.

CDC video: Why Flu Vaccination Matters: Personal Stories from Families Affected by Flu. 2014 update: Influenza Vaccine and Egg Allergy: Nearing the End of an Evidence-based Journey http://buff.ly/1tHY0wd References: JCAAI - Joint Council of Allergy Asthma and Immunology, http://www.jcaai.org
Related:
Devastated parents call on UK government to offer flu vaccine to all children http://goo.gl/B7tsX Diagram of influenza virus nomenclature. Image source: Wikipedia, GNU Free Documentation License.

Official EpiPen App for iPhone/iPad and Android

The free MyEpiPenApp was created to assist people at risk for an allergic emergency, or those who care for someone at risk, share information about their allergies and symptoms.

Within this free app, you’ll find:

- A video demonstrating how to use an EpiPen Auto-Injector

- A quick slideshow (User Guide) to help you visually walk someone through the three steps of an EpiPen injection

- The ability for you and your healthcare professional to create multiple allergy profiles listing allergens to avoid and symptoms that may indicate an allergic emergency

- The ability to share the User Guide and your allergy profile(s) with anyone via email

MyEpiPenApp may be used without entering any information that directly identifies you. Information that you record is stored only on your iPhone, iPad, or iPod touch. Dey Pharma, L.P. does not collect personal information when you use the MyEpiPenApp application.

References:
Training of trainers on epinephrine autoinjector use increases correct use from 23.3% to 74.2% http://goo.gl/lMfSR
Image source: EpiPen.com.

Asthma research and treatment options - University of California video (28 minutes)



Asthma - latest research and treatment options - University of California video (28 minutes): If you suffer from asthma, coughing, wheezing, and shortness of breath can be part of your daily routine. Want to inhale some new information about this chronic disease? Join expert Michael J. Welch, MD, and our host David Granet, MD, as they discuss the latest research and treatment options.

Series: Health Matters [11/2008] [Health and Medicine] [Show ID: 14194]

What is the typical cost of IVIG therapy (intravenous immunoglobulin) for primary immunodeficiency?

Treatment of patients with primary immunodeficiency disease with IVIG is expensive.

The average product and administrative cost per infusion in physicians’ offices in the United States in 2005 was $2,075. This includes a product cost of $1,807 for 32 grams of IVIG and $268 in administrative costs for a 3-hour infusion.

If we adjust this data from 2005 to reflect consumer price index inflation we would expect the average infusion to cost approximately $2,262 (as of year 2008). At one infusion every four weeks, this represents an average annual cost of $29,406 per patient.


Antibody function: each antibody binds to a specific antigen; an interaction similar to a lock and key. Image source: Wikipedia.

References:
Impact of intravenous immunoglobulin (IVIG) treatment among patients with Primary
Immunodeficiency diseases
. Pharmaceuticals Policy and Law, 10 (2008), 133–146 (PDF).

7 Tips for Allergy-free Winter

7 Tips for Allergy-free Winter by the American College of Allergy, Asthma and Immunology (ACAAI):

1. Reduce humidity (moisture) in your home to keep dust mites in check. Maintain humidity below 50-55%. Don’t use a humidifier or a vaporizer.

2. Filter out dust and other allergens by installing a high efficiency furnace filter with a MERV rating of 11 or 12. Change it every 3 months.

3. Banish allergens from the bedroom (where you spend a third of your life). Keep pets and their dander out, and encase mattresses and pillows with dust-mite proof covers. Limit curtains – use blinds that can be washed instead.

4. Keep your home clean. Wear a NIOSH-rated N95 mask while dusting. Wash bedding and stuffed animals in hot water every 14 days and use a vacuum with a HEPA filter.

5. Turn on the fan or open the window to reduce mold growth in bathrooms (while bathing) and kitchens (while cooking). Wear latex-free gloves and clean visible mold with a 5% beach solution and detergent.

6. Don’t overlook the garage if it’s attached to the house - noxious odors or fumes can trigger asthma. Move insecticides, stored gasoline and other irritants to a shed. Don’t start the car and let it run in the garage.

7. Box up books and knick-knacks and limit the number of indoor plants. When you are buying new furniture, like chairs or sofas, opt for leather or other nonporous surfaces to make cleaning easier.



Dust mite allergen avoidance. The main allergen is in the dust mite feces. Use 3 control measures for 3-6 months to see an effect on the allergy symptoms (click to enlarge the image).

Where are highest concentrations of dust mites found in home? Pillows, stuffed animals, mattress, bedding? http://goo.gl/l6KtR -- A: Mattress.

References:

Leave Winter Allergy and Asthma Misery Out in the Cold Allergists Offer Tips for Eliminating Indoor Triggers

Image source: picturestation.net, free license.